(Q48464426)

English

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

scientific article published in March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

attention deficit hyperactivity disorder

0 references

1 reference

based on heuristic

inferred from title

Joseph Biederman

1

object named as

Joseph Biederman

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

Robert L Findling

5

object named as

Robert L Findling

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

2

object named as

Suma Krishnan

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

author name string

Yuxin Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

James J McGough

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

29

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

450-463

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Attention deficit-hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylphenidate: increased abuse or appropriate use?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

How Informative Are Parent Reports of Attention-Deficit/Hyperactivity Disorder Symptoms for Assessing Outcome in Clinical Trials of Long-Acting Treatments? A Pooled Analysis of Parents' and Teachers' Reports

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980083-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(07)80083-X

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17577466

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48464426&oldid=2199556068"